Polypeptide expressed in the stratum corneum and use thereof

Patent metadata

Field	Value
Publication number	US-9617307-B2
Application number	US-201514736666-A
Country	US
Kind code	B2
Filing date	Jun 11, 2015
Priority date	Apr 27, 2010
Publication date	Apr 11, 2017
Grant date	Apr 11, 2017

Abstract

Polypeptides belonging to the family of late proteins of the cornified envelope (LCE), fragments of the polypeptide, isolated nucleotide sequences encoding the polypeptides, and cosmetic and/or pharmaceutical compositions containing such polypeptides are described. The polypeptides have cosmetic and/or therapeutic use to reinforce the barrier function of the epidermis, prevent and/or treat the signs of skin dryness and prevent and/or treat disorders of the barrier function or the weakening of the epidermis.

First claim

The invention claimed is:

1. A method for reinforcing the cornified envelopes in the stratum corneum of the epidermis by establishing covalent bonds between peptides belonging to the family of late cornified envelope (LCE) proteins and said cornified envelopes, under the action of endogenous transglutaminases, comprising the administration of an effective amount of at least one polypeptide to a subject in need thereof,
said polypeptide belonging to the family of late proteins of the cornified envelope (LCE), said polypeptide being a fragment of the sequence SEQ ID NO: 2, said fragments having a length of 15 amino acids or less and of at least 5 consecutive amino acids within SEQ ID NO: 2 and having at least one glutamine (Gln)-lysine (Lys) domain within said at least 5 consecutive amino acids.

2. The method of claim 1 , wherein the subject is being treated for signs of skin aging.

3. The method according to claim 1 , wherein the subject is being treated for thinning of the epidermis and/or the stratum corneum, and/or excessive fragility of the skin, and/or for inducing thickening of the stratum corneum.

4. The method according to claim 1 , wherein the subject in need thereof is suffering from at least one of hyperkeratosis, xerosis, ichthyoses, psoriasis, benign or malignant hyperkeratotic tumoral lesions, or reactive keratosis.

5. The method of claim 1 , wherein said fragment of the sequence SEQ ID NO: 2 has a length of at least 9 consecutive amino acids.

6. The method of claim 1 , wherein said at least one polypeptide has the sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, and mixtures of said polypeptides thereof.

7. The method of claim 3 , wherein said fragment of the sequence SEQ ID NO: 2 has a length of at least 9 consecutive amino acids.

8. The method of claim 3 , wherein said at least one polypeptide has the sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, and mixtures of said polypeptides thereof.

Assignees

• Chanel Parfums Beaute
• Centre Nat De La Rech Scientifique—Cnrs
• Univ Toulouse 3 Paul Sabatier
• Univ Paul Sabatier (Toulouse Iii)
• Centre Nat Rech Scient

Inventors

• Jonca Nathalie
• Toulza Eve
• Saintigny Gaelle
• Serre Guy
• Weber Vivat Marina

Classifications

• A61P37/04

  Immunostimulants · CPC title

• A61P17/02

  for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

• A61P17/16

  Emollients or protectives, e.g. against radiation · CPC title

• A61P17/06

  Antipsoriatics · CPC title

• A61P17/00

  Drugs for dermatological disorders · CPC title